biologics – EuropaWire.eu

↧

AstraZeneca selects Cambridge Biomedical Campus for its new global R&D centre...

June 21, 2013, 1:47 pm

Move brings AstraZeneca’s small molecule and MedImmune’s biologics research and development together at purpose-built facility on Cambridge Biomedical Campus 21-6-2013 — /europawire.eu/ — AstraZeneca...

View Article

AstraZeneca’s global biologics research and development arm MedImmune...

October 10, 2013, 6:27 am

London, United Kingdom, 10-10-2013 — /EuropaWire/ — AstraZeneca today announced that on 4 October MedImmune, its global biologics research and development arm, completed its acquisition of Amplimmune,...

View Article

SGS to expand its biopharmaceutical testing capabilities in Geneva with a new...

September 3, 2018, 10:23 pm

GENEVA, 04-Sep-2018 — /EuropaWire/ — SGS, a leading bio/pharmaceutical analytical and bioanalytical contract solutions provider, today announced it is expanding its biopharmaceutical testing...

View Article

AstraZeneca, Acerta Pharma, MedImmune to present at the 2018 American Society...

November 29, 2018, 4:44 am

27 scientific presentations, including long-term data from Calquence in mantle cell lymphoma and updated early-phase trial results in chronic lymphocytic leukaemia New data on six medicines and...

View Article

Image may be NSFW.
Clik here to view.

Hong Kong listed WuXi Biologics to operate Bayer’s final drug product...

January 16, 2020, 2:25 am

Plants in Leverkusen will be operated by WuXi Biologics and will serve as a back-up site for final product manufacturing of Kovaltry. Photo: T Branding. (PRESS RELEASE) LEVERKUSEN, 16-Jan-2020 —...

View Article